Neuroradiology:高灌注引起的脑梗死?还是脑梗死后高灌注?

2019-05-31 佚名 脑血管病及重症文献导读

65岁,女性。既往高血压病史。因为突发表达性失语就诊,无其他神经功能缺损。

65岁,女性。

既往高血压病史。

因为突发表达性失语就诊,无其他神经功能缺损。

CT 未见颅内出血,CTA 未见血管闭塞。

CT 灌注显示左侧额叶皮层小片灌注异常,CBF 和 CBV增加,为高灌注表现(下图)。CTA(dynamic subtraction CTA rendering of CT perfusion)显示皮层静脉提前充盈(early contrast filling)。不除外动静脉分流:



随后头 MRI 显示相应区域弥散受限,符合缺血的表现(下图):



MRA 未见明显异常。

患者症状患者,随访也未发生其他新的症状。给予氯吡格雷和辛伐他汀治疗。

6周后随访4D-CT 未见任何异常,无 AV 分流的征象。

原始出处:Anna Koopman, Frank-Erik de Leeuw, Frederick Meijer. CT perfusion hypervolemia: brain ischemia or stroke mimic? Neuroradiology. April 2019

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1951225, encodeId=f6ee19512259e, content=<a href='/topic/show?id=44fd10249309' target=_blank style='color:#2F92EE;'>#高灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102493, encryptionId=44fd10249309, topicName=高灌注)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Dec 08 09:33:00 CST 2019, time=2019-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465142, encodeId=33a51465142d7, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Sun Jun 02 06:33:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367125, encodeId=80c536e125a6, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:41:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1951225, encodeId=f6ee19512259e, content=<a href='/topic/show?id=44fd10249309' target=_blank style='color:#2F92EE;'>#高灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102493, encryptionId=44fd10249309, topicName=高灌注)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Dec 08 09:33:00 CST 2019, time=2019-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465142, encodeId=33a51465142d7, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Sun Jun 02 06:33:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367125, encodeId=80c536e125a6, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:41:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-02 karmond
  3. [GetPortalCommentsPageByObjectIdResponse(id=1951225, encodeId=f6ee19512259e, content=<a href='/topic/show?id=44fd10249309' target=_blank style='color:#2F92EE;'>#高灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102493, encryptionId=44fd10249309, topicName=高灌注)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Dec 08 09:33:00 CST 2019, time=2019-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465142, encodeId=33a51465142d7, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Sun Jun 02 06:33:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367125, encodeId=80c536e125a6, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:41:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-01 133d9d3cm85暂无昵称

    学习了,谢谢

    0